CCR4 versus CCR10 in human cutaneous TH lymphocyte trafficking - PubMed (original) (raw)
Comparative Study
. 2003 Mar 1;101(5):1677-82.
doi: 10.1182/blood-2002-07-2348. Epub 2002 Oct 24.
Affiliations
- PMID: 12406880
- DOI: 10.1182/blood-2002-07-2348
Free article
Comparative Study
CCR4 versus CCR10 in human cutaneous TH lymphocyte trafficking
Dulce Soler et al. Blood. 2003.
Free article
Abstract
The chemokine receptors (CCRs) CCR4 and CCR10, and the cutaneous lymphocyte antigen (CLA), have each been proposed as critical mediators of skin-specific TH lymphocyte homing in mice and humans. CLA initiates skin homing by mediating E-selectin-dependent tethering and rolling within cutaneous venules, but the specific roles of CCR4 and CCR10 are unclear. We have generated an antihuman CCR10 monoclonal antibody (mAb; 1B5) to illuminate the individual contributions of these molecules. This mAb allows us to compare CCR10, CCR4, and CLA expression within human TH populations. The mAb 1B5 recognizes functional CCR10 expression, as chemotactic responsiveness to cutaneous T-cell-attracting chemokine (CTACK)/CCL27 (a CCR10 ligand) parallels the staining of TH subsets. We find CCR10 expressed by only a minority (approximately 30%) of blood-borne, skin-homing (CLA+/CCR4+) TH cells. However, essentially all members of the relatively small "effector" (CLA+/CCR4+/CD27-/CCR7-) skin-homing TH population express CCR10. Most skin-infiltrating lymphocytes in allergic delayed-type hypersensitivity (DTH) and bacterial chancroid skin lesions express both CCR4 and CLA, but only about 10% express CCR10. This suggests for the 2 models of TH skin homing studied here that CCR10+ TH cells have no advantage over other CLA+/CCR4+ TH cells in homing to cutaneous sites. We conclude that the skin-homing TH compartment is itself divided into distinct subpopulations, the smaller of which expresses both CCR4 and CCR10, and the larger of which expresses only CCR4. Thus, CCR10 is unlikely to be necessary for cutaneous homing of TH cells in the models studied here. CCR10 may instead play a role in the movement of specialized "effector" cutaneous TH cells to and/or within epidermal microenvironments.
Similar articles
- Circulating clonal CLA(+) and CD4(+) T cells in Sezary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7.
Sokolowska-Wojdylo M, Wenzel J, Gaffal E, Lenz J, Speuser P, Erdmann S, Abuzahra F, Bowman E, Roszkiewicz J, Bieber T, Tüting T. Sokolowska-Wojdylo M, et al. Br J Dermatol. 2005 Feb;152(2):258-64. doi: 10.1111/j.1365-2133.2004.06325.x. Br J Dermatol. 2005. PMID: 15727636 - CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin.
Reiss Y, Proudfoot AE, Power CA, Campbell JJ, Butcher EC. Reiss Y, et al. J Exp Med. 2001 Nov 19;194(10):1541-7. doi: 10.1084/jem.194.10.1541. J Exp Med. 2001. PMID: 11714760 Free PMC article. - Skin-versus gut-skewed homing receptor expression and intrinsic CCR4 expression on human peripheral blood CD4+CD25+ suppressor T cells.
Iellem A, Colantonio L, D'Ambrosio D. Iellem A, et al. Eur J Immunol. 2003 Jun;33(6):1488-96. doi: 10.1002/eji.200323658. Eur J Immunol. 2003. PMID: 12778466 - Skin-homing T cells in human cutaneous allergic inflammation.
Santamaria Babi LF, Perez Soler MT, Hauser C, Blaser K. Santamaria Babi LF, et al. Immunol Res. 1995;14(4):317-24. doi: 10.1007/BF02935627. Immunol Res. 1995. PMID: 8722046 Review. - Chemokine receptors and leukocyte trafficking in the mucosal immune system.
Williams IR. Williams IR. Immunol Res. 2004;29(1-3):283-92. doi: 10.1385/IR:29:1-3:283. Immunol Res. 2004. PMID: 15181289 Review.
Cited by
- T-cell positioning by chemokines in autoimmune skin diseases.
Richmond JM, Strassner JP, Essien KI, Harris JE. Richmond JM, et al. Immunol Rev. 2019 May;289(1):186-204. doi: 10.1111/imr.12762. Immunol Rev. 2019. PMID: 30977191 Free PMC article. Review. - LPSlow-Macrophages Alleviate the Outcome of Graft-_Versus_-Host Disease Without Aggravating Lymphoma Growth in Mice.
Jeljeli M, Chêne C, Chouzenoux S, Thomas M, Segain B, Doridot L, Nicco C, Batteux F. Jeljeli M, et al. Front Immunol. 2021 Aug 3;12:670776. doi: 10.3389/fimmu.2021.670776. eCollection 2021. Front Immunol. 2021. PMID: 34413847 Free PMC article. - The Lymphocyte Potassium Channels Kv1.3 and KCa3.1 as Targets for Immunosuppression.
Lam J, Wulff H. Lam J, et al. Drug Dev Res. 2011 Nov;72(7):573-584. doi: 10.1002/ddr.20467. Drug Dev Res. 2011. PMID: 22241939 Free PMC article. - Vm24, a natural immunosuppressive peptide, potently and selectively blocks Kv1.3 potassium channels of human T cells.
Varga Z, Gurrola-Briones G, Papp F, Rodríguez de la Vega RC, Pedraza-Alva G, Tajhya RB, Gaspar R, Cardenas L, Rosenstein Y, Beeton C, Possani LD, Panyi G. Varga Z, et al. Mol Pharmacol. 2012 Sep;82(3):372-82. doi: 10.1124/mol.112.078006. Epub 2012 May 23. Mol Pharmacol. 2012. PMID: 22622363 Free PMC article. - Chemokine receptor requirements for epidermal T-cell trafficking.
Tubo NJ, McLachlan JB, Campbell JJ. Tubo NJ, et al. Am J Pathol. 2011 Jun;178(6):2496-503. doi: 10.1016/j.ajpath.2011.02.031. Am J Pathol. 2011. PMID: 21641376 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
- AI27863/AI/NIAID NIH HHS/United States
- AI31494/AI/NIAID NIH HHS/United States
- AI46784/AI/NIAID NIH HHS/United States
- MO1RR00750/RR/NCRR NIH HHS/United States
- T32AI07367/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous